SCHEMBL9900623

SCHEMBL9900623

CCCCN(Cc1cccc([N+](=O)[O-])c1)C(=O)OC(C)(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
NPSR1 Q6W5P4 1/20 0.51
HTT P42858 2/20 0.49
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
LMNA P02545 3/20 0.46
MAPT P10636 4/20 0.45
PYCR1 P32322 1/20 0.43
GRIN2D O15399 1/20 0.43
GRIN3B O60391 1/20 0.43
GRIN1 Q05586 1/20 0.43
GRIN2A Q12879 1/20 0.43
GRIN2B Q13224 1/20 0.43
GRIN2C Q14957 1/20 0.43
GRIN3A Q8TCU5 1/20 0.43
ACHE P22303 1/20 0.42
AR P10275 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15498167 0.93 CYP1A2 (0.49) ALDH1A1SMN1; SMN2NPSR1HTTCYP1A2
SCHEMBL18994885 0.92 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2NPSR1HTTCYP1A2
SCHEMBL30877118 0.91 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2NPSR1HTTCYP1A2
SCHEMBL30877102 0.90 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2NPSR1HTTCYP1A2
SCHEMBL16467912 0.90 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2HTTCYP1A2CYP2D6
SCHEMBL3127049 0.89 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2HTTCYP1A2CYP2D6
SCHEMBL6674347 0.89 CYP1A2 (0.54) ALDH1A1SMN1; SMN2HTTCYP1A2CYP2D6
SCHEMBL16468408 0.87 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2HTTCYP1A2CYP2D6
SCHEMBL16467927 0.86 SLC2A1 (0.49) ALDH1A1SMN1; SMN2LMNAMAPTACHE
SCHEMBL16467937 0.86 LPAR1 (0.44) ALDH1A1SMN1; SMN2HTTCYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011072241-A9 4-OXO-1H-QUINOLINE-3-CARBOXAMIDES AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-06-14 WO disclosed